Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)

We report two cases of recurrent thrombotic thrombocytopenic purpura, both patients without significant personal pathological antecedents, in which the evolution was favorable following the association of Caplacizumab with the classic treatment with plasmapheresis and cortisone therapy. We studied t...

Full description

Bibliographic Details

Published in:	Documenta Haematologica
Main Authors:	Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU
Format:	Article
Language:	English
Published:	Romanian Society of Hematology 2025-03-01
Subjects:	thrombotic thrombocytopenic purpura caplacizumab platelets adamts 13
Online Access:	https://www.dhrrh.ro/wp-content/uploads/2025/03/DHRRH-2025-1-art6.pdf